Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 18;12:1756286418819074. doi: 10.1177/1756286418819074

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Laboratory outcomes.

Profile plots show variations of laboratory outcomes over time in relation to the use of IFN-β1a alone or in combination with Coenzyme Q10 (Group 1: group receiving Coenzyme Q10 from baseline to 3-month follow up is in red; Group 2: group receiving Coenzyme Q10 from 3- to 6-month follow up is in green). Coefficients (Coeff) and p values are shown from mixed-effect linear regression models where an interaction term between treatment and time was set and marginal effects were calculated.

IFN-β1a, interferon-beta1a.